These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21720729)

  • 1. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 4. Technology assessment applied to the spine.
    Andersson GB; Kirkpatrick JS
    Spine (Phila Pa 1976); 2008 Sep; 33(19):2025-7. PubMed ID: 18698278
    [No Abstract]   [Full Text] [Related]  

  • 5. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 6. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 7. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 8. Robotics in trauma and orthopaedics.
    Karuppiah K; Sinha J
    Ann R Coll Surg Engl; 2018 May; 100(6_sup):8-15. PubMed ID: 29717889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of preventive measures using scientific methods].
    Göhlen B; Bossmann H
    Med Klin (Munich); 2010 Oct; 105(10):724-9. PubMed ID: 20981592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance for future HTA applications to vaccines: the HPV lesson.
    La Torre G; de Waure C; Chiaradia G; Mannocci A; Capri S; Bamfi F; Ricciardi W
    Hum Vaccin; 2011 Sep; 7(9):900-4. PubMed ID: 21865880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review.
    Gallego G; Harris A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):615-7. PubMed ID: 21155692
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of the quality of mini-HTA.
    Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
    Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspective.
    Cheung RY; Mui V
    J Diabetes Sci Technol; 2015 May; 9(3):706-10. PubMed ID: 25697719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery system innovation and Health Technology Assessment: Upgrading from Clinical to Technological Assessment.
    Panzitta M; Bruno G; Giovagnoli S; Mendicino FR; Ricci M
    Int J Pharm; 2015 Nov; 495(2):1005-18. PubMed ID: 26399633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced technologies, to the fore in 2020.
    Haddad FS
    Bone Joint J; 2020 Jan; 102-B(1):1-2. PubMed ID: 31888360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.